Business
Exercise of warrant and issue of equity
Exercise of warrant and issue of equity.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 9732D OptiBiotix Health PLC 06 February 2018 \n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n \nExercise of warrant and issue of equity\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes has received a notification for the exercise of warrants over 800,000 ordinary shares in the Company at an exercise price of 8p per share, providing the Company with proceeds of £64,000.\n \nApplication will be made to the London Stock Exchange to admit the 800,000 new ordinary shares to trading on AIM. Admission of the new ordinary shares is expected to occur on or around 9 February 2018. The new ordinary shares will rank pari passu with the existing ordinary shares.\n \nFor the purpose of the Disclosure and Transparency Rules, following the issue of shares detailed above the enlarged issued share capital of the Company will comprise 80,485,712 ordinary shares of 2p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.\n \nThis announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 and the person who arranged for release of this announcement on behalf of the Company was Mark Collingbourne, Chief Financial Officer.\n \nFor further information, please contact:\n \n\n\n\n\nOptiBiotix Health plc\n\n\nwww.optibiotix.com\n\n\n\n\nStephen O'Hara, Chief Executive\n\n\nContact via Walbrook below\n\n\n\n\n\n\n\n\n\n\n\n\nCairn Financial Advisers LLP\n\n\nTel: 020 7213 0880\n\n\n\n\nLiam Murray / Jo Turner\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nfinnCap Broker\n\n\nTel: 020 7220 0500\n\n\n\n\nAdrian Hargrave / Scott Mathieson / Kate Bannatyne (Corporate Finance)\n\n\n\n\n\n\n\nTony Quirke (Corporate Broking)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Ltd\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nAnna Dunphy\n\n\nMob: 07876 741 001\n\n\n\n\n\n\n\n\n\n \nAbout OptiBiotix - www.optibiotix.com \nOptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of...